Clinical Features and Prognosis of 60 Cases of HIV-negative Plasmablastic Lymphomas Patients
10.3971/j.issn.1000-8578.2021.20.0878
- VernacularTitle:60例HIV阴性浆母细胞淋巴瘤患者的临床特征及预后
- Author:
Wenjing XU
1
;
Pei WANG
;
Yueshi MA
;
Liping GAO
Author Information
1. Department of Oncology, Chongqing Traditional Chinese Medicine Hospital, Chongqing 400021, China
- Publication Type:Research Article
- Keywords:
Lymphoma;
Clinical features;
Treatment;
Prognosis
- From:
Cancer Research on Prevention and Treatment
2021;48(4):375-380
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the clinical features and prognosis of HIV-negative plasmablastic lymphoma (PBL) patients. Methods We collected HIV-negative PBL cases reported in our hospital and other literatures from online databases from January 1, 1997 to March 30, 2020. The data of clinical features, molecular pathology, treatment and prognosis were summarized and analyzed. Results We included 60 PBL patients, average age was 53.06±14.36 years, and most of them had relatively high Ann Arbor stage and Ki-67 expression. The average OS was 13.48±13.21 m. Kaplan-Meier curve revealed Ann Arbor stage, IPI index (3-5), B symptoms and CR in initial treatment were significantly related with patients' survival. Cox regression analysis indicated that the Ann Arbor stage and IPI index were the independent prognostic factors for patients' survival. Conclusion HIV-negative PBL mostly occurs in the middle-age and elderly patients, with advanced diagnosis stage and rapid tumor proliferation. Combination chemotherapy is the main treatment, while the therapeutic response and OS might be heterogeneous, the prognosis of most patients would be poor. The stage and IPI index are significantly related to the prognosis.
